| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/27/2007 | CN1985987A Medicine composition of glycyrrhizic acid or its salt and reduced glutathione |
| 06/27/2007 | CN1985854A Plant lactobacillus composition and its application in strengthening intestinal immunobarrier |
| 06/27/2007 | CN1985804A Glutathione based delivery system |
| 06/27/2007 | CN1323167C Muteins of placental growth factor type 1, preparing method and application thereof |
| 06/27/2007 | CN1323166C King crab element gene and method of expression |
| 06/27/2007 | CN1322897C Use of IL-18 inhibitors |
| 06/27/2007 | CN1322896C Acupuncture point injection mixture for treating mastopathy proliferation, its preparing method and application |
| 06/27/2007 | CN1322815C Method for preparing cleansing facial milk |
| 06/26/2007 | USRE39705 Method of treating glutathione deficient mammals |
| 06/26/2007 | US7235685 Of tumors and other lesions; phototherapeutic effect is caused by direct interaction of free radicals, the reactive intermediate produced upon photofragmentation of the sulfenate moiety, with the tissue of interest |
| 06/26/2007 | US7235654 administration of siRNA directed to IKK alpha to cells and SiRNA can be 21 to 25 nucleotides in length and hybridize to a nucleic acid molecule encoding human IKK alpha; for treating autoimmune and inflammatory disease in a mammal |
| 06/26/2007 | US7235653 Oligonucleotide compositions and methods for the modulation of the expression of B7 protein |
| 06/26/2007 | US7235650 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis |
| 06/26/2007 | US7235649 Diagnosis and treatment of disorders related to Hsp90 protein function |
| 06/26/2007 | US7235644 Vaccine against Gram-negative bacterial infections |
| 06/26/2007 | US7235639 Reaction product with nucleic acid crosslinking agent such as psoralen; intercalate between base pairs of nucleic acids in material to be decontaminated and on ex vivo exposure to ultraviolet light; enhances oxygen carrying capacity of blood in subjects with bacterial, viral, or retroviral infections |
| 06/26/2007 | US7235638 Nuclleotide sequences coding polypeptide for use in the treatment of blood disorders |
| 06/26/2007 | US7235635 IRAK-4: compositions and methods of use |
| 06/26/2007 | US7235634 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases |
| 06/26/2007 | US7235631 For altering T cell-mediated immune responses |
| 06/26/2007 | US7235629 To modulate ligand induced signaling |
| 06/26/2007 | US7235628 Analogues of GLP-1 |
| 06/26/2007 | US7235627 Derivatives of GLP-1 analogs |
| 06/26/2007 | US7235625 Administering phosphodiestarase inhibitors and melanocortin receptor antagonist: synergistic mixture |
| 06/26/2007 | US7235590 Administering treosulfan, busulfan, dimethyl busulfan, pentasulfan or hepsulfam to a person in a procedure that is not stem cell transplantation; for treatment of relapsing-remitting, primary progressive and in particular secondary progressive MS |
| 06/26/2007 | US7235534 Oligonucleotide or polynucleotide for treating vascular healing after surgery, preventing atherosclerotic plaque, vein graft healing, cardiovascular disorders |
| 06/26/2007 | US7235532 Angiogenic agents and their uses |
| 06/26/2007 | US7235531 Tachykinin-like polypeptides and use thereof |
| 06/26/2007 | US7235530 Preventing or reducing blood loss, cerebral ischemia or the onset of systemic inflammatory response associated with a surgical procedure by administering a non-naturally occurring kallikrein inhibitor polypeptide in combination with an anti-thrombolytic agent |
| 06/26/2007 | US7235529 Brain-associated inhibitor of tissue-type plasminogen activator |
| 06/26/2007 | US7235528 Immunopotentiator for mammary gland of dairy cows containing lactoferrin as an active ingredient |
| 06/26/2007 | US7235527 Polypeptide for use in the treatment bone disorders and osteoarthritis |
| 06/26/2007 | US7235526 Protein kinase C peptides for use in withdrawal |
| 06/26/2007 | US7235525 administering an effective amount of erythropoietin for treatment to a patient with renal failure-associated osteodystrophy or renal failure-associated osteoporosis |
| 06/26/2007 | US7235524 Luteinizing hormone in an administrable form which ensures an increase in plasma levels for 40-60 hours |
| 06/26/2007 | US7235523 Methods for the treatment of hepatic disorders |
| 06/26/2007 | US7235522 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
| 06/26/2007 | US7235521 A method of determining whether a peptide having a Glutamine-Phenylalanine (QF) and upstream or downstream helical structure relative to the QF amide bond is a Previn |
| 06/26/2007 | US7235520 Admininstering neutrophil gelatinase associated lipocalin (NGAL) polypeptide for treatment of immune disorders; autocrine |
| 06/26/2007 | US7235403 Culturing a cell in the presence or absence of the compound, assaying the cell for expression or activity of gene(s), detecting the compound when expression of the genes is lower in the presence of the compound than in the absence |
| 06/26/2007 | US7235390 Mixture of Aspergillus derived protease, lipase, amylase and cellulase, and calcium, zinc, manganese, and magnesium cofactors; improved digestion |
| 06/26/2007 | US7235380 CDR-grafted anti-tissue factor antibodies and methods of use thereof |
| 06/26/2007 | US7235372 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 06/26/2007 | US7235371 Human osteoclast derived cathepsin |
| 06/26/2007 | US7235368 CHP for use as marker for sepsis-type inflammatory diseases |
| 06/26/2007 | US7235366 Methods of identifying agonists and antagonists of opioid receptors |
| 06/26/2007 | US7235362 Compositions and methods for protein isolation |
| 06/26/2007 | US7235269 comprises mixing acetone with acid extracted solubles from a defatted soybean material to form a precipitate, and diluting and ultrafiltering to obtain a retentate |
| 06/26/2007 | US7235253 Stabilization by adding to the aqueous liquid at least one compound selected from the group consisting of a nonionic surfactant, a water-soluble, nonionic, organic binder, hydrogenated lecithin, and mannitol. |
| 06/26/2007 | US7235249 Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions |
| 06/26/2007 | US7235248 Pharmaceutical compositions comprising cyclosporins |
| 06/26/2007 | US7235247 Aqueous solution; efficient penetration |
| 06/26/2007 | US7235244 Compositions and methods for treating papillomavirus-infected cells |
| 06/26/2007 | US7235243 Immunological combination compositions and methods |
| 06/26/2007 | US7235241 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
| 06/26/2007 | US7235240 A mutein of IL-15 at least one deletion or substitution in two positions of the amino acid sequence; transplant rejection, autoimmune diseases, inflammatory bowel disease, skin disorders, gatrointestinal disorders, vision defects; antiarthritic, anticarcinogenic, and antidiabetic agents |
| 06/26/2007 | US7235239 Antibodies to a chemokine expressed in inflamed adenoid |
| 06/26/2007 | US7235238 Antibodies that bind receptor protein designated 2F1 |
| 06/26/2007 | US7235237 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 06/26/2007 | US7235236 A replication-defective adenoviral or adeno-associated viral vector; gene therapy for congestive heart failure |
| 06/26/2007 | US7235232 Interferon alpha hybrids |
| 06/26/2007 | US7234469 Surface topography method for determining effect of a botulinum toxin upon a muscle |
| 06/26/2007 | CA2494473C Stabilized protein compositions for topical administration and methods of making same |
| 06/26/2007 | CA2349930C Bioactive prostheses with immunosuppressive, antistenotic and antithrombotic properties |
| 06/26/2007 | CA2307792C Method for regulating size and growth of vascularized normal tissue |
| 06/26/2007 | CA2295316C Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy |
| 06/26/2007 | CA2290739C New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 06/26/2007 | CA2265464C Therapy for .alpha.-galactosidase a deficiency |
| 06/26/2007 | CA2244268C Nucleoside analogs in combination therapy of herpes simplex infections |
| 06/26/2007 | CA2216704C Novel peptides and remedy for bone diseases containing the same as active ingredient |
| 06/26/2007 | CA2215372C Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 06/26/2007 | CA2186423C Protein which induces interferon-gamma production by immunocompetent cell |
| 06/26/2007 | CA2185037C Iridaceae extract and compositions containing the same |
| 06/26/2007 | CA2157118C Isolation of components of interest from milk |
| 06/26/2007 | CA2139862C Use of p97 and iron binding proteins as diagnostic and therapeutic agents |
| 06/26/2007 | CA2065797C Monoclonal antibody, polypeptide and production thereof |
| 06/21/2007 | WO2007070672A2 Non-natural amino acids and neurotensin analogues thereof |
| 06/21/2007 | WO2007070564A2 Methods of treating obesity using enterostatin |
| 06/21/2007 | WO2007070563A2 Stable solid forms of enterostatin |
| 06/21/2007 | WO2007070562A2 Non-hygroscopic compositions of enterostatin |
| 06/21/2007 | WO2007070509A2 Epithelial sodium channel inhibiting agents and uses therefor |
| 06/21/2007 | WO2007070450A2 Fast-acting oral peptide pharmaceutical products |
| 06/21/2007 | WO2007070390A2 Method for prolonging activity of autodegradable enzymes |
| 06/21/2007 | WO2007070372A2 Compositions and methods for inhibiting cellular proliferation |
| 06/21/2007 | WO2007070307A2 Intravenous essential fatty acid emulsion |
| 06/21/2007 | WO2007069839A1 Novel use of erythropoietin protein |
| 06/21/2007 | WO2007069716A1 Composition having effect of inhibiting visceral fat accumulation |
| 06/21/2007 | WO2007068983A1 New treatment |
| 06/21/2007 | WO2007068895A1 Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer |
| 06/21/2007 | WO2007068803A1 Novel neurotrophic factor protein and uses thereof |
| 06/21/2007 | WO2007068784A1 Novel neurotrophic factor protein and uses thereof |
| 06/21/2007 | WO2007068736A2 New chemokine antagonists |
| 06/21/2007 | WO2007068718A1 Polypeptide protracting tags |
| 06/21/2007 | WO2007068163A1 Hiv fusion inhibitor peptides and use thereof |
| 06/21/2007 | WO2007068055A1 A method for preventing reduced feed intake in animals and treatment of disease conditions |
| 06/21/2007 | WO2007068053A1 Recombinant protein production |
| 06/21/2007 | WO2007068039A1 Treatment of weight gain in estrogen deficient mammals |
| 06/21/2007 | WO2007047551A3 Methods and compositions for derepression of iap-inhibited caspase |
| 06/21/2007 | WO2007047489A3 Compositions and methods for use in cancer therapy |
| 06/21/2007 | WO2007041719A3 Combination therapy using budesonide and antisense oligonucleotide targeted to il4-receptor alpha |